We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

14:HKEXHysan Development Co., Ltd. Analysis

Data as of 2026-03-17 - not real-time

HK$1.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading well below its short‑term and medium‑term moving averages, with the short‑term average under the medium‑term, signalling a bearish momentum. Momentum oscillators are in oversold territory and the MACD histogram remains negative, while trading volume has been tapering, suggesting limited buying pressure. The price is hovering just above a clear support zone and below a notable resistance level, framing a tight range for the near term.
Fundamental backdrop: Despite a modest contraction in revenue, the company maintains healthy gross and operating margins and generates solid cash flow. Its balance sheet is strong, featuring abundant cash relative to debt and a low debt‑to‑equity profile. Valuation multiples are well beneath sector averages, with price‑to‑book and price‑to‑earnings ratios indicating a discount, and discounted cash‑flow analysis points to a price nearly double the current level. Analysts are collectively bullish, assigning a strong‑buy consensus and a median price target substantially higher than today’s market price.
Strategic considerations: The consumer‑defensive positioning in the packaged‑foods segment offers resilience amid economic cycles, while the company’s expanding online presence adds a growth avenue. However, the high recent volatility and a historical drawdown exceeding half of its peak value underscore the need for careful timing. Overall, the market appears to undervalue the stock relative to its intrinsic worth, presenting a compelling entry point for investors with a medium‑to‑long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical momentum with price below key averages
  • Oversold conditions may limit further downside
  • Proximity to a defined support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside relative to discounted cash‑flow estimate
  • Strong cash generation and low leverage
  • Analyst consensus of strong‑buy and elevated target price

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Defensive consumer segment provides stable demand
  • Robust margins and cash flow support sustainable growth
  • Long‑term upside potential as the market re‑prices intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth-2.90%
Profit Margin7.18%
P/E Ratio15.6
ROE4.83%
ROA2.76%
Debt/Equity7.90
P/B Ratio0.7
Op. Cash FlowHK$433.4M
Free Cash FlowHK$371.1M

Technical Analysis

TrendBearish
RSI31.1
SupportHK$1.36
ResistanceHK$1.76
MA 20HK$1.54
MA 50HK$1.60
MA 200HK$2.05
MACDBearish
VolumeDecreasing
Fear & Greed Index79.5

Valuation

Fair ValueHK$2.91
Target PriceHK$2.74
Upside/Downside95.41%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.14
Volatility41.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.